Furthermore, there was a notable decline in gamma-glutamyl transpeptidase (GGT, 138.0U/L (NR, 9-150U/L)) levels in conjunction with hypoalbuminemia (25.4 g/L (NR, 35–50 g/L)), hypofibrinogenemia (0.5 g/L (NR, 2–4 g/L)), abnormalities of coagulation (international normalized ratio (INR): 2.4 (NR, 0.8–1.2), subsequent to vitamin K1 injection), hypoglycemia(1.6mmol/L (NR, 3.9-6.1mmol/L)), and normal blood ammonia. This evidence concerns the gene GGTLC1 and Hypofibrinogenemia.